|
IL1RAP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.648600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.467600E-01 |
| Normal-vs-Stage2 |
9.088000E-01 |
| Normal-vs-Stage3 |
6.037700E-02 |
| Normal-vs-Stage4 |
1.424970E-01 |
| Stage1-vs-Stage2 |
4.671200E-01 |
| Stage1-vs-Stage3 |
3.577700E-02 |
| Stage1-vs-Stage4 |
9.858300E-02 |
| Stage2-vs-Stage3 |
7.474100E-02 |
| Stage2-vs-Stage4 |
1.590980E-01 |
| Stage3-vs-Stage4 |
8.850800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.904800E-01 |
| Normal-vs-AfricanAmerican |
5.511400E-01 |
| Normal-vs-Asian |
4.268400E-01 |
| Caucasian-vs-AfricanAmerican |
6.285200E-01 |
| Caucasian-vs-Asian |
3.659000E-01 |
| AfricanAmerican-vs-Asian |
5.423600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.242600E-01 |
| Normal-vs-Female |
6.782000E-03 |
| Male-vs-Female |
1.382110E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.892200E-01 |
| Normal-vs-Extreme_Weight |
1.231430E-01 |
| Normal-vs-Obese |
1.262970E-01 |
| Normal-vs-Extreme_Obese |
9.144100E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.626190E-01 |
| Normal_Weight-vs-Obese |
3.660400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.463800E-02 |
| Extreme_Weight-vs-Obese |
2.367700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.720400E-01 |
| Obese-vs-Extreme_Obese |
1.159660E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.820300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.846200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.958000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.177550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.665900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.720300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.944330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.716400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.036800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.697400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.397900E-02 |
| Normal-VS-Type2 PRCC |
2.804400E-01 |
| Normal-VS-KIRP CIMP |
1.839000E-03 |
| Normal-VS-Unclassified PRCC |
3.201700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.394200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.398670E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.522870E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.460580E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.456800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.740300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.087000E-01 |
| Normal-vs-N1 |
1.087990E-02 |
| Normal-vs-N2 |
2.484200E-01 |
| N0-vs-N1 |
6.437400E-03 |
| N0-vs-N2 |
2.224600E-01 |
| N1-vs-N2 |
8.949000E-01 |
|
|
